IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

U.K. Pseudoephedrine Curb?

1:43 PM MDT | March 28, 2007 | Chemical Week Editorial Staff

U.K. government agency the Medicines and Healthcare Products Regulatory Agency (MHRA) has proposed a reclassification of medicines containing pseudoephedrine and ephedrine as prescription-only drugs. The substances are often used in over-the-counter cold and flu treatments. The reclassification could hurt manufacturers of pseudoephedrine and ephedrine, because pharmaceutical companies may respond to the changes by formulating new medicines that omit the two products. BASF has slashed jobs and reduced psuedoephedrine production at Minden, Germany during the past...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa